(PharmaNewsWire.Com, May 17, 2017 ) The Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market research report, published by Market Data Forecast estimates that the market itself was worth $0.84 billion in 2016 and expected to grow at a CAGR of 5.92%, to reach $1.12 billion by 2021 with a cumulative growth rate of $0.28 billion in the span of five years.
Kidney cancer accounts for 3% of all human cancers and is the most frequently occurring urologic tumors. Diagnosis of this cancer is generally done by blood and urine tests, imaging tests(like CT, MRI, PET scan and ultrasound) and biopsies. Treatment options include surgery, targeted therapy, immunotherapy, chemotherapy and ablation.
High-intensity focused ultrasound(HIFU) is a fairly new technique which involves pointing very focused ultrasound beams from outside the body to destroy the tumor. Small kidney cancers can be treated by Ablation with cryotherapy or Radiofrequency Ablation(RFA). Research is still underway in these techniques to determine their long term usage as well as to refine them.
The report also presents detailed analysis of multitude of factors affecting the endoscopy devices market bearing either positive or negative outcomes. Some of those factors are: Rise in geriatric population Increasing awareness of kidney cancer Poor accessibility of proper care Volatile economies of the region Lack of awareness of proper treatment
For granular level understanding the Kidney Cancer Diagnostics and Therapeutics Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. The Asia-Pacific Kidney Cancer Diagnostics and Therapeutics market is segmented based on Type and Tests. The market for Kidney Cancer Diagnostics and Therapeutics, on the basis of Type is segmented into Transitional Cell Cancer, Renal cell carcinoma, Renal sarcoma, and Others. On the basis of Tests, the Kidney Cancer Diagnostics and Therapeutics market is segmented into Biopsy, CT Scan, Cystoscopy, Intravenous pyelogram, Kidney Ultrasound. Biopsy and CT Scan lead the tests segment in the Kidney Cancer Diagnostics and Therapeutics market.
The Asia-Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Strong economic growth in countries such as China, Japan, and Australia contributes greatly towards this market.
The major companies dominating the Kidney Cancer Diagnostics and Therapeutics market in Asia-Pacific region are GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis, Abbott Laboratories.
The Asia-Pacific Water Endoscopic Devices Market report offers wide-range of scope:
Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
Know more about key areas of industry growth via detailed Segment-level analysis on basis of product type long with market size forecasts and y-o-y estimations
Detailed explanation of major drivers, restraints, opportunities, and challenges (DROC) that affect the market and impact the ever-shifting market dynamics
Strategic Analyses containing PESTLE and Porters Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
